Molecules Containing Cyclobutyl Fragments as Therapeutic Tools: A
Review on Cyclobutyl Drugs
-
Published:2022-06-10
Issue:23
Volume:29
Page:4113-4135
-
ISSN:0929-8673
-
Container-title:Current Medicinal Chemistry
-
language:en
-
Short-container-title:CMC
Author:
Ren Shuang1ORCID,
Pan Fei1,
Zhang Wen1,
Rao Guo-Wu1ORCID
Affiliation:
1. College of Pharmaceutical Science, Zhejiang University of Technology, and Institute of Drug Development
& Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, P.R. China
Abstract
Abstract:
In recent years, cyclobutyl has become more influential in the field of drug design.
Its unique four-membered ring structure is not only a useful intermediate for the
synthesis of biomedical candidate materials but also an indispensable framework for drug
design and application. According to the therapeutic field, cyclobutyl drugs are roughly
divided into tumor and cancer drugs, nervous system drugs, analgesics, antiviral drugs,
and gastrointestinal drugs. Among them, platinum-based anticancer drugs containing cyclobutyl
fragments have achieved remarkable success in the treatment of cancer, bringing
new hope for the development of more cyclobutyl drugs. This article provides details of
the research progress of the structure types, structure-activity relationships, targets, and
mechanisms of cyclobutyl drugs that have been on the market or are in the clinical stage
and provides ideas for the discovery and synthesis of novel cyclobutyl-containing drugs.
Funder
Science and Technology Program of Zhejiang Province
National Natural Science Foundation of China
Zhejiang Provincial Natural Science Foundation of China
National Undergraduate Training Program for Innovation and Entrepreneurship of China
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献